董宇;张英风;杨庆;李玉洁;朱晓新;
DONG Yu1,ZHANG Yingfeng2,YANG Qing2,LI Yujie2,ZHU Xiaoxin2(1.Institute of Chinese Materia Medica,Guang'anmen Hospital,Beijing 100053,China;2.Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China)

• 1:中国中医科学院广安门医院
• 2:中国中医科学院中药研究所

摘要(Abstract)：

目的:研究炒白芍提取物中芍药苷(Pae)在大鼠不同肠段的肠外翻囊模型中的吸收动力学特征及其与P-gp的相互作用。方法:采用大鼠肠外翻囊模型,以Pae为炒白芍提取物中代表成分,用HPLC对其进行检测,计算Pae的肠吸收动力学参数,分析Pae的肠吸收特征。结果:炒白芍提取物不同浓度时Pae在不同肠段的吸收均为线性吸收,其回归相关系数的平方(R2)均>0.9以上,符合零级吸收;其Ka随给药剂量的增加而增加,说明其为被动吸收。Pae在不同肠段吸收总趋势为空肠>回肠>结肠。炒白芍提取物与维拉帕米(Ver)合用时,Pae在回肠中吸收显著增加(P<0.05);口服炒白芍提取物后,在回肠段对Rho 123的外排量增加(P<0.01)。结论:Pae在肠道中吸收为零级吸收,吸收机制为被动吸收。Pae可能为P-gp底物,炒白芍提取物能诱导肠道中P-gp的表达。
Objective: To research the intestinal Absorption characteristics of paeoniflorin in extractive Radix Paeoniae Alba in the different intestinal segment,and the interaction with P-glycoprotein.Method: Paeoniflorin,a representative component in extractive Radix Paeoniae Alba,on the intestinal Absorption was studied in vitro using everted gut sacs model and detected by HPLC method.The Absorption characteristics was evaluated by the Absorption parameter.Result: The Absorption of paeoniflorin was linearity at different intestine segment and dose,and the square of regrees correlation coefficient exceed 0.9(R2>0.9),which consistent with zero order rate process.The Kα of paeoniflorin showed a dose-dependent increase along with the raised dose of extractive Radix Paeoniae Alba,indicated it was a mechanism of passive Absorption.The Absorption rate was jejunum>ileum>colon.Verapamil(100 μmol·L-1),a inhibitor of the P-glycoprotein,can remarkable increase the Absorption of the paeoniflorin in ileum(P<0.05).After administer the extractive Radix Paeoniae Alba for 5 days,the extraction of Rho123 is significantly increase in ileum(P<0.01).Conclusion: The intestinal Absorption of paeoniflorin is zero order rate process and passive Absorption.Paeoniflorin is a substrate of P-glycoprotein,and extractive Radix Paeoniae Alba could induce the expression of the P-glycoprotein.

关键词(KeyWords)： 炒白芍提取物;肠外翻;芍药苷;P-糖蛋白;HPLC
extractive Radix Paeoniae Alba;everted gut sacs;paeoniflorin;P-glycoprotein;HPLC

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目(30371722,30701097);; 国家“十一五”科技支撑计划项目(2006BAI08B04-4)

作者(Author): 董宇;张英风;杨庆;李玉洁;朱晓新;
DONG Yu1,ZHANG Yingfeng2,YANG Qing2,LI Yujie2,ZHU Xiaoxin2(1.Institute of Chinese Materia Medica,Guang'anmen Hospital,Beijing 100053,China;2.Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China)

Email:

DOI:

参考文献(References)：

• [1]张茂清,马猛.白芍总苷的临床研究进展[J].儿科药学杂志,2006,12(1):48.
• [2]胡南,许惠玉,陈志伟,等.芍药苷的药理学研究进展[J].齐齐哈尔医学院学报,2007,18(9):1093.
• [3]Berruet N,Sentenac S,Auchere D,et al.Effect of efavirenz onintestinal P-glycoprotein and hepatic P450 function in rats[J].JPharm Pharmacent Sci,2005,8(2):226.
• [4]Yumoto R,Murakami T,Nakamoto Y,et al.Transport of rhoda-mine 123,a P-glycoprotein substrate,across rat intestine and Ca-co-2 cell monolayers in the presence of cytochrome P-450 3A-re-lated compounds[J].J Pharmacol Exp Ther,1999,289(1):149.
• [5]Barthe L,Woodley J,Houin G.Gastrointestinal absorption ofdrugs:methods and studies[J].Fundam Clin Pharmacol,1999,13(2):154.
• [6]Kilic F S,Batu O,Sirmagul B,et al.Intestinal absorption of di-goxin and interaction with nimodipine in rats[J].Pol J Pharma-col,2004,56:137.
• [7]杨煜,吕文伟,宋瑛士,等.白芍总苷抗血栓形成作用[J].中草药,2006,37(7):1066.
• [8]Liu H Q,Zhang W Y,Luo X T,et al.Paeoniflorin attenuatesneuroinflammation and dopaminergic neurodegeneration in theMPTP model of Parkinson's disease by activation of adenosine A1receptor[J].Br J Pharmacol,2006,148(3):314.
• [9]Watanabe H.Candidates for cognitive enhancer extracted frommedicinal plants:paeoniflorin and tetramethylpyrazine[J].Be-hav Brain Res,1997,83(1/2):135.
• [10]Tabata K,Matsumoto K,Murakami Y,et al.Ameliorativeeffects of paeoniflorin,a major constituent of peony root,onadenosine A1 receptor-mediated impairment of passive avoidanceperformance and long-term potentiation in the hippocampus[J].Biol Pharm Bull,2001,24(5):496.
• [11]Wu H,Wei W,Song L,et al.Paeoniflorin induced immune tol-erance of mesenteric lymph node lymphocytes via enhancing beta2-adrenergic receptor desensitization in rats with adjuvant arthritis[J].Int Immunopharmacol,2007,7(5):662.
• [12]Liu Z Q,Jiang Z H,Liu L,et al.Mechanisms responsible forpoor oral bioavailability of paeoniflorin:Role of intestinal disposi-tion and interactions with sinomenine[J].Pharm Res,2006,23(12):2768.
• [13]Hsiu S L,Lin YT,Wen KC,et al.Adeglucosylated metaboliteof paeoniflorin of the root of Paeonia lactiflora and its pharmacoki-netics in rats[J].Planta Med,2003,69(12):1113.
• [14]Heikal O A,Akao T,Takeda S,et al.Pharmacokinetic study ofpaeonimetabolin I,a major metabolite of paeoniflorin from paeonyroots[J].Biol Pharm Bull,1997,20(5):517.
• [15]Mertens-Talcott S U,De Castro W V,Manthey J A,et al.Poly-methoxylated flavones and other phenolic derivates from citrus intheir inhibitory effects on P-glycoprotein-mediated transport of tal-inolol in Caco-2 cells[J].J Agric Food Chem,2007,55(7):2563.
• [16]Raad I,Terreux R,Richomme P,et al.Structure-activity rela-tionship of natural and synthetic coumarins inhibiting the multi-drug transporter P-glycoprotein[J].Bioorg Med Chem,2006,14(20):6979.
• [17]Shitan N,Tanaka M,Terai K,et al.Human MDR1 and MRP1recognize berberine as their transport substrate[J].Biosci Bio-technol Biochem,2007,71(1):242.